PharmaSecure

Trending Articles

  1. OINDPs: Nosey about recent developments? OINDPs are a user friendly and efficacious alternative to injectables in several disease areas
  2. Transforming healthcare with patient centricity In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...
  3. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  4. Compact process thermostat for efficient temperature control in the laboratory The temperature control system is designed for the accurate temperature control of small research reactors between -40 to +200 °C
  5. AviadoBio expands presence at Canary Wharf The company has acquired 11,000 sqft of laboratory and office space in Canary Wharf to accommodate the growing team

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

You need to be a subscriber to read this article.
Click here to find out more.
Regulatory

Stemming the tide of counterfeit medicines

Global trade in counterfeit medicines kills on a grand scale. <i>Manufacturing Chemist</i> investigates some of the worst affected areas and efforts to counter this illegal trade
You need to be a subscriber to read this article.
Click here to find out more.
Packaging

Meeting India’s mandate for serialisation

The Indian serialisation movement has led to the first large-scale, cost-effective serialisation of packages, including even inexpensive products and requires unique numbers and barcodes for every tertiary, secondary and primary package exported from India, according to GS1 standards. Many hardware providers are forming partnerships with more robust software suites to offer integrated solutions for secondary and primary DGFT serialisation.
Finance

PharmaSecure secures US$3.9m in funding

To develop drug authentication technologies and software
Subscribe now